| GFACX | LGLCX | GFACX / LGLCX | |
| Total Expense Ratio | 1.35 | 1.64 | 82% |
| Annual Report Gross Expense Ratio | 1.35 | 1.64 | 82% |
| Fund Existence | 25 years | 15 years | - |
| Gain YTD | 5.156 | 2.232 | 231% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1500 | 17% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 357B | 7.43B | 4,804% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -0.98 | 2.80 | -35% |
| Returns for 3 years | 27.74 | 73.19 | 38% |
| Returns for 5 years | 3.92 | 6.44 | 61% |
| Returns for 10 years | 76.09 | 111.23 | 68% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MAGCX | 35.22 | 0.18 | +0.51% |
| BlackRock Advantage Global Institutional | |||
| PGINX | 24.22 | 0.10 | +0.41% |
| Impax Global Environmental Markets Instl | |||
| PMVQX | 33.83 | -0.09 | -0.27% |
| PGIM Quant Solutions Mid-Cap Val R6 | |||
| RYCMX | 55.80 | -0.43 | -0.76% |
| Rydex Russell 2000 1.5x Strategy C | |||
| SHSKX | 67.59 | -0.74 | -1.08% |
| BlackRock Health Sciences Opps K | |||